International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Doan Dao, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- King Faisal Specialist Hospital and Research Center in Jeddah
Jeddah, Saudi Arabia
- National Guard Hospital in Jeddah
Jeddah, Saudi Arabia
- King Faisal Specialist Hospital and Research Centre in Riyadh
Riyadh, Saudi Arabia
- King Saud University Medical Center
Riyadh, Saudi Arabia
- National Guard Hospital in Riyadh
Riyadh, Saudi Arabia
- Binh An Hospital
Rach Gia, Kien Giang, Vietnam
- Medic Ca Mau
Ca Mau, Vietnam
- Medic Medical Center-Ho Chi Minh City
Ho Chi Minh City, Vietnam
- Dong Da Hospital
Hà Nội, Vietnam
- Institute of Gastroenterology and Hepatology
Hà Nội, Vietnam
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Apr 2022
- Primary completion
- 7 Jun 2025
- Completion
- 7 Jun 2025
- Last update posted
- 12 Jun 2025
- Registered enrollment
- 360
- Registry id
- NCT05342350
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.